InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
INW | Ann:Resignation of Director Jill McFarlane | 08/05/15 | 0 | 564 | |||
|
|||||||
INW | Ann:Final Director's Interests Notice Jill McFarlane | 08/05/15 | 0 | 540 | |||
|
|||||||
INW | Ann:Half Yearly Financials - Annexure & Statements - 31 December 2014 (Price Sensitive) | 02/03/15 | 0 | 541 | |||
|
|||||||
INW | Ann:Company request to delist - 30th of June 2015 | 09/12/14 | 0 | 613 | |||
|
|||||||
INW | News: Minutes and Results of 2014 AGM | 03/12/14 | 0 | 654 | |||
|
|||||||
INW | Initial Post | 02/11/14 | 0 | 518 | |||
|
See All Discussions